Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome

Objective The advantage of beta-blockers has been postulated in patients with Takotsubo syndrome (TTS) given the pathophysiological role of catecholamines. We hypothesised that beta-blocker treatment after discharge may improve the long-term clinical outcome in this patient population. Methods This was an observational, multicentre study including consecutive patients with TTS diagnosis…

Read the full article here

Related Articles